These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7509719)

  • 1. Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer.
    Arao S; Suwa H; Mandai M; Tashiro H; Miyazaki K; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Mar; 54(5):1355-9. PubMed ID: 7509719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDR1 gene expression in primary and advanced breast cancer.
    Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
    Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer.
    Hille S; Rein DT; Riffelmann M; Neumann R; Sartorius J; Pfützner A; Kurbacher CM; Schöndorf T; Breidenbach M
    Anticancer Drugs; 2006 Oct; 17(9):1041-4. PubMed ID: 17001177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
    Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
    Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relationship between MDR1 gene and gallbladder cancer.
    Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the multidrug resistance gene in human tumors.
    Kim R
    Hiroshima J Med Sci; 1990 Sep; 39(3):71-7. PubMed ID: 1980915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients.
    Chen YJ; Yuan CC; Chow KC; Wang PH; Lai CR; Yen MS; Wang LS
    Gynecol Oncol; 2005 Apr; 97(1):110-7. PubMed ID: 15790446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of soluble P-glycoprotein in culture media and extracellular fluids.
    Chu TM; Lin TH; Kawinski E
    Biochem Biophys Res Commun; 1994 Aug; 203(1):506-12. PubMed ID: 7915520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of the MDR1 gene and HSP27 in human ovarian cancer.
    Schneider J; Jimenez E; Marenbach K; Marx D; Meden H
    Anticancer Res; 1998; 18(4C):2967-71. PubMed ID: 9713493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
    Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the multidrug resistance gene in osteosarcoma: a pilot study.
    Wunder JS; Bell RS; Wold L; Andrulis IL
    J Orthop Res; 1993 May; 11(3):396-403. PubMed ID: 8100852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance gene and P-glycoprotein expression in anaplastic carcinoma of the thyroid.
    Yamashita T; Watanabe M; Onodera M; Shimaoka K; Ito K; Fujimoto Y; Itoyama S; Sugawara I
    Cancer Detect Prev; 1994; 18(5):407-13. PubMed ID: 7812988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment.
    Tada Y; Wada M; Kuroiwa K; Kinugawa N; Harada T; Nagayama J; Nakagawa M; Naito S; Kuwano M
    Clin Cancer Res; 2000 Dec; 6(12):4618-27. PubMed ID: 11156211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a human multidrug resistance gene in ovarian carcinomas.
    Bourhis J; Goldstein LJ; Riou G; Pastan I; Gottesman MM; Bénard J
    Cancer Res; 1989 Sep; 49(18):5062-5. PubMed ID: 2766278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer.
    Shin HJ; Lee JS; Hong WK; Shin DM
    Anticancer Res; 1992; 12(2):367-70. PubMed ID: 1374598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.